(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃 (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran 915095-89-5
(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃
依帕列净杂质10;5-溴EMPAGLIFLOZIN杂质;恩帕格列净溴杂质;恩格列净溴代物;(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基];(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃;(S)-3-(4-(2-氯-5-溴苄基)-苯氧基)-四氢呋喃;依帕列净中间体1
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
EMpagliflozinint3;Empagliflozin-7;915085-89-5;EmpagliflozinBromoImpurity;(S)-4-bromo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene;3-[4-[(5-broMo-2-chlorophenyl)Methyl]phenoxy]tetrahydro-;(3S)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydro-furan;(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane915095-89-5
915095-89-5
C17H16BrClO2
367.66
1.431±0.06 g/cm3 (20 ºC 760 Torr)
49-51°C
459.1±45.0 °C(Predicted)
可溶于DMSO（少许）、甲醇（少许）
Sealed in dry,Room Temperature
用途
(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃用作反应物，利用AlCl3-促进的硅烷还原β-吡喃果糖苷有效合成SGLT-2依格列净抑制剂。
用途
依帕列净中间体
